Shandong Bailong Chuangyuan Bio-tech Co. Ltd. Class ASSE: 605016

"Shandong Bailong Chuangyuan Bio-Tech Co., Ltd."Notice on the 2nd Extraordinary General Meeting in 2026

Sep 23, 2026 · Issued by Shandong Bailong Chuangyuan Bio-tech Co. Ltd. Class A via Shanghai Stock Exchange

Notice on the 2nd Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Shandong Bailong Chuangyuan Bio-tech Co. Ltd. Class A

"Shandong Bailong Chuangyuan Bio-Tech Co., Ltd."Announcement on Implementation of Dividend Distribution for the First Half of 2026Sep 22
"Shandong Bailong Chuangyuan Bio-Tech Co., Ltd."Indicative Announcement on Update to the Prospectus (Registration Draft) and Other Application Documents Submitted for the Issuance of Convertible Corporate Bonds to Unspecified InvestorsSep 11
"Shandong Bailong Chuangyuan Bio-Tech Co., Ltd."Announcement on Establishment of a Wholly-owned Subsidiary in Kunming through External InvestmentSep 10
"Shandong Bailong Chuangyuan Bio-Tech Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance and Cash Dividend BriefingAug 31

All Shandong Bailong Chuangyuan Bio-tech Co. Ltd. Class A news releases